Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.

S Chalil, B Stegemann, SA Muhyaldeen, K Khadjooi, PW Foley, RE Smith, F Leyva

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT). Methods: Sixty‐two patients with heart failure (age 67.3 ± 9.6 yrs [mean ± SD], 45 males, New York Heart Association class [NYHA] class III or IV, left ventricular ejection fraction [LVEF]= 35%, left bundle branch block, QRS  ≥ 120 ms) underwent late gadolinium enhancement cardiovascular magnetic resonance (LGE‐CMR) for scar imaging. Patients were followed up for 741 (75–1602) days (mean [range]). Results: The presence of a PL scar emerged as an independent predictor of the composite endpoint of cardiovascular death or hospitalization for worsening heart failure (HR: 3.06 [1.63, 7.7, P < 0.0001]) as well as the endpoint of cardiovascular death (HR: 2.63 [1.39, 6.65], P = 0.0016). A transmural PL scar was the strongest predictor of these endpoints (both P < 0.0001). The symptomatic responder rate (improvement by ≥1 NYHA classes or ≥25% in 6‐min walking distance) was 83% in the group with non‐PL scars, but only 47% in the group with transmural PL scars (P < 0.0001). Pacing over the scar was associated with a higher mortality and morbidity than pacing outside the scar (all P < 0.05). Conclusions: A PL scar is associated with a worse clinical outcome following CRT, particularly if it is transmural. Pacing scarred left ventricular myocardium carries a greater risk of mortality and morbidity than pacing nonscarred myocardium.
Original languageEnglish
Pages (from-to)1201-1209
JournalPacing and Clinical Electrophysiology
Volume30
Issue number10
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Dive into the research topics of 'Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.'. Together they form a unique fingerprint.

Cite this